Citation Tools

other Versions

Download PDFPDF

A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial

Download to a citation manager

Cite this article as:
Ottenbourgs T, van Gorp T, Kridelka F, et al
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial